LifeStance Health (LFST) Net Income towards Common Stockholders (2020 - 2026)

LifeStance Health (LFST) has 7 years of Net Income towards Common Stockholders data on file, last reported at $14.2 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 1908.89% year-over-year to $14.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $23.2 million (up 165.09% YoY) and the FY2025 annual result came in at $9.7 million, up 116.82% from the prior year.
• Net Income towards Common Stockholders climbed to $14.2 million in Q1 2026 per LFST's latest filing, from $11.7 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $14.2 million in Q1 2026 and bottomed at -$68.7 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is -$23.3 million (2024), against an average of -$25.6 million.
• The widest annual swing landed in 2023, when Net Income towards Common Stockholders sank 62.69%; it then jumped 1908.89% in 2026.
• Tracing LFST's Net Income towards Common Stockholders over 5 years: stood at -$46.7 million in 2022, then climbed by 3.64% to -$45.0 million in 2023, then jumped by 84.18% to -$7.1 million in 2024, then soared by 264.06% to $11.7 million in 2025, then increased by 22.07% to $14.2 million in 2026.
• Per Business Quant, the three latest LFST Net Income towards Common Stockholders figures stand at $14.2 million (Q1 2026), $11.7 million (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison